New investment supports continued expansion of LJM’s technology, analytics and strategic shipping advisory services

FARMINGDALE, N.Y., Aug. 18, 2026 — LJM, a technology-enabled parcel shipping advisory and management company, today announced a strategic partnership with Clearview Capital, a private investment firm. The transaction, which closed May 6, 2026, brings additional resources to support LJM’s continued growth while preserving the expertise and high-touch service model that clients rely on today.

For LJM clients, the partnership will maintain continuity in day-to-day service while enabling increased investment in the company’s technology, analytics and advisory capabilities. LJM plans to accelerate investment in its Parcel Intelligence Platform™, scale its advanced analytics and service offerings, and expand its Executive Shipping Advisory to support holistic, integrated shipping strategies for its largest clients.

The partnership arrives at a time when parcel shipping is becoming an increasingly strategic expense for businesses. In Boston Consulting Group’s 2025 Parcel Study, 90% of shippers indicated that reducing parcel delivery costs is a core challenge in managing parcel logistics.

UPS and FedEx are increasingly prioritizing value and margin over volume, while dynamic pricing, more frequent rate changes and expanding accessorial charges are making parcel costs harder to predict and manage. For shippers, these changes make data-driven carrier negotiations, service optimization and network strategy increasingly important.

“This is about building on what already works,” said Ken Wood, Founder and Chief Executive Officer at LJM. “Our clients will continue receiving the same hands-on expertise they expect from LJM. What changes is our ability to invest more aggressively in the technology, data and capabilities behind that service. Parcel shipping is becoming more complex every year, and this partnership gives us additional resources to help clients see their costs more clearly, make better-informed decisions and manage shipping as an integrated component of their broader business strategy.”

LJM combines proprietary technology and robust parcel data with deep carrier-side expertise to help businesses manage and reduce parcel spend. Its services span carrier contract negotiation and ongoing rate optimization, parcel analytics, invoice audit and recovery, and strategic shipping advisory. LJM’s Parcel Intelligence Platform™ provides centralized access to shipping and spend data, shipment-level reporting, alerts and cost-trend analysis, giving businesses greater visibility into parcel performance and the ability to continuously optimize shipping costs and strategy.

Over more than two decades, LJM has built its business around measurable client outcomes and a high-touch approach to parcel management. Today, the company serves more than 1,500 businesses and has processed more than 5.5 billion parcels, combining technology with experienced parcel professionals to help shippers navigate increasingly complex carrier pricing and operating environments.

“What stood out to us about LJM is the consistency and quality with which the company delivers measurable, valuable outcomes to its clients,” said Geoff Faux, Partner of Clearview Capital. “In an environment where parcel shipping costs remain a significant and increasing expense for businesses, LJM has developed a highly differentiated platform and a proven ability to generate tangible savings for its clients. These attributes position LJM well for its next phase of growth, and we are excited to support the team as they continue to expand the company’s capabilities and build on that success.”

About LJM

LJM is a technology-enabled parcel shipping advisory and management company that helps businesses understand, manage and reduce parcel spend. Combining the Parcel Intelligence Platform™, advanced analytics and deep carrier-side expertise, LJM provides carrier contract negotiation and ongoing rate optimization, parcel analytics, audit and recovery, and executive shipping advisory services. LJM serves more than 1,500 businesses and has processed more than 5.5 billion parcels.

Learn more at myljm.com.

About Clearview Capital

Clearview Capital is a private investment firm founded in 1999, focused on acquiring and recapitalizing lower middle-market companies in North America. The firm has completed more than 150 transactions across diverse industries and is headquartered in Stamford, Connecticut, with additional offices in California and Tennessee.

SOURCE LJM

GRAND RAPIDS, Mich., Aug. 18, 2026 — Capitan Orthopedics, Inc. (https://capitanortho.com/) announced today that it has closed its oversubscribed Seed round, bringing its total capital raised to date to $4.1 million.

Chance W. Leonard, CEO of Capitan Orthopedics, Inc., commented, “I am extremely excited to announce that we have not only closed our Seed round, but have oversubscribed by over $1.1 million dollars. In addition to our recent receipt of FDA Breakthrough Device Designation, our team continues to reach milestone achievements at an accelerated pace. Today is yet another special day in our rapidly progressing project timeline.”

Capitan Orthopedics, Inc. intends to use the funds to continue its project development and validation efforts and begin its first in-human clinical trial, which is expected to begin in Q1 2027.

Mr. Leonard also added, “We remain very encouraged by our continued progress on this innovative project, the strength of the unmet clinical need and the unique opportunity it creates. Our investors clearly recognize this opportunity, and their capital investment demonstrates significant confidence in the work we are doing. The progress we are making to deliver to the market a solution that is simple, reproducible, and cost effective is exceptional. With core development complete and a clear regulatory path ahead, we look forward to beginning our first in human clinical trial as soon as possible.”

R. Sean Churchill, MD, MBA, shoulder reconstruction specialist, and surgeon design team member, “For decades surgeons have struggled with the irreparable rotator cuff tear. For those patients 65 years and older, the reverse total shoulder arthroplasty provides outstanding results. However, for the younger, active patients with an irreparable rotator cuff tear, there remains a void in surgical treatment options. The SupraSpacer™ stands to fill that gap with a durable, metallic implant that maintains the humeral head aligned with the glenoid throughout a full shoulder range of motion while preserving 90% of the humeral head cartilage. The seven-step surgical procedure is straightforward, reproducible, and ideal for utilization in the ambulatory surgery center.”

About Capitan Orthopedics, Inc.

Capitan Orthopedics, Inc. is an innovator in the design of orthopedic implant products for shoulder surgery. The company has developed the SupraSpacer™ implant and procedure to successfully address the critical unmet need of irreparable rotator cuff tears in younger, active patients. This novel technology fills a distinct gap in the current care continuum and provides surgeons with a simple, reproducible solution that integrates smoothly into existing surgical workflows. The system is purpose-built for the ASC setting and includes sterile-packaged instruments and implants to support procedural efficiency. 

Capitan Orthopedics, Inc. is backed by Genesis Innovation Group, Inc. (https://genesisinnovationgroup.com/), a leader in medical device development and commercialization and represents a compelling opportunity to bring a first-in-class solution to a large, underserved patient population. For investment information, please contact the company at 1-833-444-2468.

https://genesisinnovationgroup.com

https://capitanortho.com 

SOURCE Capitan Orthopedics, Inc.

JANESVILLE, Wis., Aug. 18, 2026 — As U.S. nuclear fuel recycling moves toward commercial reality, SHINE, a fusion energy company with a platform serving the nuclear fuel recycling market, is working with GE Vernova on a project to develop a modernized and more efficient system to track spent fuel throughout the recycling process.

Led by GE Vernova’s Advanced Research Center, the company’s central technology development hub, the project — funded by the Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) program — aims to use artificial intelligence to optimize spent nuclear fuel tracking and measurement at recycling facilities. As a GE Vernova subcontractor, SHINE is developing improved sensor deployment and AI-powered material-tracking systems that would help incorporate material control and accountability into nuclear fuel recycling facilities from the very start.

“There’s a better way to handle material control and accountability at spent nuclear fuel recycling facilities — one that doesn’t mean permanent cost and disruption,” said Ross Radel, SHINE CTO. “As a company designing a recycling process of its own, SHINE is joining the GE Vernova-led collaboration to tackle the design challenge of building modern accountability and safeguards into nuclear recycling facilities from day one. Get that right, and these facilities will be more cost-effective and have less downtime.”

Economic viability is at the core of the project, which is developing technology known as Monochromatic Assays Yielding Enhanced Reliability, or MAYER, for spent nuclear fuel recycling facilities. The technology is intended to track and measure nuclear material in real time as it flows through a recycling facility and feed that information into a virtual digital twin, strengthening security safeguards while significantly reducing operating costs.

Currently, nuclear operators may use redundant instrumentation, physical security measures, repeated manual sampling and periodic shutdowns to carry out inventory checks of nuclear material within a facility. Material control and accounting are part of a larger safeguards program run by the U.S. Nuclear Regulatory Commission to ensure nuclear material is not stolen or otherwise diverted.

SHINE’s work on the MAYER project supports its broader goal of building a commercial nuclear fuel recycling facility that would be classified in a lower-security NRC category, significantly reducing the physical security burden and cost.

Along with the MAYER collaboration, SHINE announced today another partnership designed to pave the way for practical nuclear fuel recycling that turns nuclear “waste” into an energy resource. These technologies support the cost competitiveness SHINE is seeking in its Recover Elements – Destroy Undesirables – Create Energy nuclear fuel recycling process, called REDUCE for short. Together, they advance SHINE’s work toward the first commercial application of advanced recycling technologies that aim to enable the efficient, proliferation-resistant extraction of uranium, plutonium and other high-value materials from spent nuclear fuel.

About SHINE

SHINE is a fusion energy company headquartered in Janesville, Wisconsin. We are leading the transition to the fusion economy through a vertically-integrated platform that supplies critical products to global markets, each one funding the next.

Today, we supply defense and research customers with neutron-based testing. Our medical radioisotopes diagnose heart disease and treat cancer, and the world’s largest commercial-scale medical isotope facility is now under construction. We are developing the technology to recycle used nuclear fuel, targeting a commercial pilot to draw down the 94,000 metric tons that have accumulated in the United States. Our long-term purpose is to put fusion energy on the grid. Learn more at www.shinefusion.com.

About GE Vernova
GE Vernova Inc. (NYSE: GEV) is a purpose-built global energy company that includes Power, Electrification, and Wind segments and is supported by its accelerator businesses. Building on over 130 years of experience tackling the world’s challenges, GE Vernova is uniquely positioned to help lead the energy transition by continuing to electrify the world while simultaneously working to decarbonize it. GE Vernova helps customers power economies and deliver electricity that is vital to health, safety, security, and improved quality of life. GE Vernova is headquartered in Cambridge, Massachusetts, U.S., with approximately 85,000 employees across 100+ countries around the world.

GE Vernova’s Advanced Research segment is an innovation powerhouse, operating at the intersection of science and creativity to turn cutting edge research into impactful realities. Advanced Research collaborates with GE Vernova’s businesses across a broad range of technical disciplines to accelerate the energy transition.

SOURCE SHINE Technologies, LLC

Smack is scaling the domain-specific AI that allows America’s warfighters to achieve Decision Dominance across the Joint Force.

AUSTIN, Texas, Aug. 18, 2026 — Smack Technologies, the first frontier AI lab for national security, today announced it has raised a $61 million Series B financing round led by Costanoa Ventures and First In, with participation from Point72 Ventures, Geodesic Capital, Nomi Capital, Felicis, Sapphire Ventures, Scribble Ventures, Fortitude Ventures, Bloomberg Beta, and Palumni VC. The round brings Smack’s total capital raised to over $90 million as they rapidly expand their Decision Dominance platforms across the Joint Force.

The new funding will enable Smack to build the proprietary hardware necessary to deploy Alpha, its tactical AI platform, directly to the edge. While Smack’s Omega platform supports strategic planning at the command level, Alpha extends those decision-making capabilities to warfighters operating in comms and compute constrained environments. Unlike commercial LLMs, Smack’s AI is purpose-built to reason through the physics, resource constraints, and operational complexity of warfare. Smack will also use the new funding to rapidly increase model scope across domains and warfighting functions, and to recruit top AI research and engineering talent.

“The next peer-level conflict won’t be won by the side with the most sensors and effectors. It will be won by the side with Decision Dominance, the side that can turn information and capabilities into action the fastest,” said Andy Markoff, CEO and co-founder of Smack Technologies. “The DoW needs the entire decision-making process to become more autonomous while still making the correct decisions in an increasingly complex battlespace. Getting this right means putting humans in the process where they are ethically and strategically valuable — and removing humans from the part where they’re not.”

But right now, the defense industry is pursuing autonomy that only targets the platform: how independently a drone can navigate, how many vehicles one operator can control, or whether a swarm can coordinate against a target. These are real engineering problems, but they don’t answer the military question that decides a campaign: can a distributed force act coherently toward its objective, while comms degrade in a DDIL environment, resources are running out, and the adversary adapts in real time. Autonomy has to be solved at the level of the campaign, not the platform. 

This is Intelligent Autonomy: campaign-level decision-making at the speed of the fight, decentralized to the edge. 

Together, Smack’s Omega and Alpha platforms put Intelligent Autonomy in the field. Omega supports campaign-level reasoning at the command level, while Alpha pushes that same reasoning to warfighters and autonomous systems at the tactical edge. The result is an AI reasoning layer across echelons and warfighting functions. This is how Smack delivers Decision Dominance to the Department of War, and how America and her allies will win the next peer-level conflict.

“The nature of warfare doesn’t change, but its velocity absolutely does. Warfighters today may have better situational awareness, but what they need is decision-making support at machine speed,” said Arthur Karell, General Partner at First In. “Smack is leading the production of fight-tonight AI decision-making models, and we couldn’t be prouder to support its highly experienced team of operators and researchers as they deploy these advanced models downrange.”

“You can’t simply fine-tune a commercial large language model, call it defense tech and expect to win a peer-level fight,” said Greg Sands, Founder & Managing Partner at Costanoa. “That requires both a detailed understanding of sensors and effectors and the hard-earned, tacit knowledge that lives in the heads of people who’ve made decisions under fire. It also requires the right model for the mission, which is more likely to be small and physics-based than large and language-based. Smack is the first team we’ve seen build the training environment to capture that expertise and turn it into models that work everywhere the fight happens — from the command center to the tactical edge, including in low-compute, disconnected environments where cloud-dependent systems simply can’t operate.”

About Smack Technologies
Smack Technologies is the first frontier AI lab built for national security, delivering Decision Dominance to the Joint Force. Co-founded in 2024 by MARSOC veterans, Smack is building domain-specific AI models for the singular purpose of deterring — or winning if necessary — the next peer-level conflict. The company’s products, Omega and Alpha, are designed to cut across decision-making silos within the DoW, enabling campaign planning in minutes and plan updates in seconds across all time horizons for the United States, its allies, and partners. Smack is hiring world-class AI engineers and researchers and continues to build its team of leaders from all branches of the military and defense. Visit https://smacktechnologies.com/careers to join the fight.

Media Contact
[email protected]

SOURCE Smack Technologies

Round exclusively led by Qiming Venture Partners; proceeds to fund China registration trial and overseas early-stage clinical development

SHANGHAI and HANGZHOU, China, Aug. 17, 2026 — Enginprime Medical (“Enginprime” or the “Company”), a developer of percutaneous ventricular assist device (pVAD) technology, today announced the closing of a $12M Series A financing round, exclusively led by Qiming Venture Partners. Proceeds will fund the registration clinical trial of OpusOne™ in China and support regulatory submissions and early-stage clinical development of the platform globally.

Founded in 2023 by Voyagers Capital and a team of experienced engineers, Enginprime is developing next-generation percutaneous ventricular assist systems. The company’s lead product, OpusOne™, is designed to deliver higher flow rates from a smaller catheter profile.

“We are deeply grateful to Qiming Venture Partners and Voyagers Capital for their strategic support,” said Zhiyong Liu, Chief Executive Officer of Enginprime. “This funding marks a pivotal milestone as we advance and scale a globally competitive pVAD system. We are committed to executing our global clinical and regulatory strategies to deliver reliable, cost-effective percutaneous ventricular assist solutions to market.”

Shuo Mao, Principal of Qiming Venture Partners said, ” The foldable impeller pVAD achieves greater flow capacity with a lower-profile design, effectively reducing clinical complications and broadening patient eligibility and clinical applicability. It delivers significant clinical value for ventricular assist therapy. To date, no comparable product has obtained global regulatory approval, representing an untapped technological frontier in the industry. We believe that with solid industrial expertise and profound clinical insights, coupled with the joint efforts of its core team and shareholders, Enginprime’s differentiated pVAD innovation is poised to fill the global market gap and bring substantial therapeutic benefits to patients worldwide.”

“Enginprime came out of Voyagers Capital’s Venture Creation model, and the team has more than delivered on the bar we set when we started the company,” said Fiona Zhang, Partner at Voyagers Capital. “We see a clear gap and opportunities in the global pVAD market, and look forward to bringing OpusOne™ to the market in China and globally with the support of Qiming Venture Partners and other strategic partners.”

About Enginprime Medical

Enginprime was established in 2023 and incubated by Voyagers Capital, leveraging cross-disciplinary engineering capabilities, systems integration expertise, and advanced manufacturing methodologies. OpusOne™, as the company’s flagship medical device platform, is actively advancing clinical validation to support future global commercialization.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 80 portfolio companies that have achieved unicorn or super unicorn status.

About Voyagers Capital

Voyagers Capital is a healthcare venture capital fund focused on creating long-term value through strategic investments in innovations. We partner with visionary entrepreneurs to bring transformative products to patients globally.

For more information, please contact:

[email protected]; [email protected].

SOURCE Enginprime Medical Inc; Voyagers Capital

DES MOINES, Iowa, Aug. 17, 2026 — Wells Fargo announced today at the Iowa State Fair that it is making a $1.5 million investment to Habitat for Humanity to focus on innovative and affordable housing options in towns and rural communities across the country.

“Housing affordability is a growing challenge in Iowa and across the country,” said Jason Rosenberg, head of Public Affairs at Wells Fargo. “Through our partnership with Habitat for Humanity, we’re advancing growth-focused solutions so communities across the nation, greater Des Moines and rural Iowa can continue to thrive.”

As the nation faces a severe housing shortage, many families are struggling to stay in communities where they have established roots. Through this initiative, Habitat will advance alternative housing solutions, such as modular construction, an off-site building technique where pieces of the home are built in a factory and then transported to a permanent foundation.

One of the key advantages of modular construction is its efficiency, helping Habitat expand access to affordable homeownership by reducing build timelines and easing project logistics for local Habitat affiliates, particularly in areas where volunteer and contractor availability is limited. Modular homes meet or exceed local and state building codes, ensuring quality, safety and durability.

From this investment, $1 million will go to Habitat for Humanity International to advance housing innovation, including modular construction. Wells Fargo is providing Greater Des Moines Habitat for Humanity with $500,000 in funding to expand affordable housing solutions in towns and rural communities in central Iowa, such as Perry and Indianola.

“Along with our traditional home building model, modular homes are an added solution to the housing affordability crisis,” said J. Edwin Hensley, director, U.S. construction at Habitat for Humanity International. “This is a national push. With the support of Wells Fargo, we have the opportunity to prove this can work in rural, suburban and urban communities.”

Beyond this investment, Wells Fargo employees volunteered with Greater Des Moines Habitat for Humanity at the state fair to build wheelchair ramps for local homeowners. The most affordable home is the one a person already lives in, and this project will highlight the importance of people being able to age in place or live with a disability, keeping them in a home where they feel physically safe and financially secure.

“Homeownership creates stability for families and strengthens communities,” said Lance Henning, CEO of Greater Des Moines Habitat for Humanity. “For far too many Iowans, homeownership feels out of reach. Everyone should be able to afford to live in the community where they work and where their kids go to school. This investment from Wells Fargo will help support new affordable homeownership opportunities right here in Iowa and all across the country.”

Wells Fargo aligns with community leaders who highlight how housing shortages are not only affecting individual households but the economic growth of the entire community.

“This generous investment to Habitat for Humanity will make a real difference for families in rural communities like Indianola and Perry. In smaller towns, every new home means another family can put down roots, build a future, and contribute to the community they love and call home,” said Congresswoman Ashley Hinson. “I’m grateful to Wells Fargo for investing in stronger communities and more opportunities for Iowa families. I’ll keep working across the aisle to make the American Dream of home ownership attainable again.”

For more than 30 years, Habitat for Humanity International and Wells Fargo have worked together to increase housing affordability and help build more prosperous communities around the world. Since 2015, Wells Fargo & Company and the Wells Fargo Foundation have donated more than $105 million to Habitat for Humanity International and local affiliates in support of affordable and sustainable housing, including support for new home construction and repairs, helping older adults age in their homes, and neighborhood revitalization and disaster response efforts.

About Habitat for Humanity

Habitat for Humanity is a movement of people in your local area and around the world, working together to build more prosperous and vibrant communities by making sure everyone has a safe, affordable place to call home. Since our founding in 1976 as a Christian organization, together we have helped more than 65 million people globally build their futures on their own terms through access to decent housing. We’ve done that by working alongside people of all walks of life to build, repair and finance their homes, by innovating new ways of building and financing, and by advocating for policies that make constructing and accessing housing easier for everyone. Together, we build homes, communities and hope. To learn more, visit habitat.org

www.habitat.org/newsroom

SOURCE Habitat for Humanity International

Funding will bring E3’s safety platform to more schools, hospitals, and government facilities

LOGAN, Utah, Aug. 17, 2026 — Emergent 3 (“E3”), the emergency situational awareness and response platform that gives organizations real-time clarity during a crisis, today announced a strategic investment from Arthur Ventures (“AV”), an early growth capital firm that leads investments in B2B software companies. The partnership provides E3 with growth capital and strategic support for its product roadmap and continued expansion across the K-12, healthcare, and government markets.

E3 serves more than 1,000 school districts, hospitals, and government facilities across 48 states, with over 100,000 users on the platform. While most safety tools stop at alerting users that an incident is occurring, E3 answers the questions that drive outcomes: which exits are safe, whether to evacuate or lock down, who is accounted for, and what responders need to know before they arrive.

E3 recently launched two features for K-12 customers. Roll Call is a student accountability tool that syncs with a district’s student information system, allowing administrators to take roll during any emergency and see which students are accounted for, which are safe, and which need to be found first. Reunification manages and documents the student-parent reunification process from staging to release, giving schools a verified record of every student’s safe return. Both build on E3’s existing platform, which includes Smart Maps, location-aware alerts, first responder access, and drill management.

“We built this as dads who wanted something better for our own kids” said PK Keller, Founder of E3. “From day one, our goal has been simple: an end-to-end school safety platform that is easy to use and just works. It’s been rewarding to see educators and first responders share E3 with one another and help bring the platform into healthcare and government.”

“After helping grow another software company, I wanted to build something with real purpose,” said Dalton Mickelsen, CEO of E3. “From day one, E3 has been intentional about the markets we serve and focused on protecting people when it matters most.”

About Emergent 3

Emergent 3 (E3) is the emergency situational awareness and response platform that gives organizations the clarity to protect their people when seconds matter. When an emergency happens, any staff member can trigger a location-aware alert, and leadership sees the incident unfold on an interactive map of the organization’s own floor plans – who is safe, who needs help, and where each person is. With built-in Smart Maps, real-time accountability, first responder access, drill reporting, and reunification, E3 provides coordinated action for schools, hospitals, and government facilities. The platform requires no additional hardware and serves thousands of facilities across the nation. Learn more at Emergent3.com.

About Arthur Ventures

Arthur Ventures is an early growth capital firm that leads investments in B2B software companies located outside Silicon Valley. Since 2013, they have partnered with 80+ companies in different cities across all regions of the United States and Canada. Arthur Ventures manages ~$2 billion and is actively investing out of its $800 million in capital committed to its 2025 fund vintages. Learn more at arthurventures.com.

SOURCE Emergent 3

Jeanty joins as an investor and the face of Nukleus, giving athletes and the professionals who manage their careers one shared source of truth instead of scattered spreadsheets and side conversations.

ISSAQUAH, Wash., Aug. 17, 2026 — Nukleus, a career operating system for the business of sports, today announced that Las Vegas Raiders running back Ashton Jeanty has joined the platform as an investor and its face, ahead of its public launch later this month. The partnership puts one of the NFL’s rising stars behind a system built to solve a problem most athletes live with: a career run by a team, an agent, a lawyer, a CPA, a financial advisor, a marketing agent, working off scattered emails, PDFs, and spreadsheets instead of one shared source of truth. Nukleus replaces the fragments with one platform, giving everyone in an athlete’s orbit the same data at the same time.

“The athlete is the nucleus. Everyone around them, from agents and lawyers to brands and advisors, should be operating off the same information, not chasing it down separately every time something changes,” said Hector Rivas, founder and CEO of Nukleus. “I’ve spent years around the business of sports, watching deals, data, and decisions get lost between people who know they’d be better off working together, but never had a way to actually do it. Nukleus is the system that keeps them on the same team.”

Rivas founded and ran a sports agency, giving him visibility into every piece of the business, not just one. That experience shapes Nukleus’s AI infrastructure, built on a knowledge base of collective bargaining agreements, contract structures, and athlete benefits to support the professionals working on an athlete’s behalf.

“Coming into the NFL, you become a CEO, directing a team of agents, advisors, and marketers, whether you’re ready or not. Nukleus is what finally gets them all on the same page, so I can actually run that team the way it should be run. That’s why I invested in it,” said Jeanty.

Unlike athlete-only tools, Nukleus serves the full ecosystem of sports: athletes join free, while the agents, CPAs, advisors, marketing agencies, brand collectives, trainers, and lawyers who serve them subscribe to run their side of the business.

Nukleus’s leadership team includes founder and CEO Hector Rivas, who previously led ThriftBooks to more than $150 million in annual revenue; CTO Eric Ahlstrom (ESPN, Microsoft, Oracle); Chief Creative Officer Ben Miller (former creative director, University of Washington Football and CAA Sports); and CFO Matt Porter (former Controller, Disruptive Sports).

Nukleus opens to the public later this month. More information is available at nukleus.co.

About Nukleus

Nukleus is the operating system for the business of sports, connecting athletes with the agents, lawyers, CPAs, financial advisors, and marketing professionals who manage their careers. Nukleus replaces fragmented tools with a single shared system and is based in Washington state. Learn more at nukleus.co.

Contact:

Doug Hall

[email protected]

SOURCE Nukleus

Shared leadership structure formalizes how the founders already lead the company as the Aptitude enters its next stage of growth

GOLETA, Calif., Aug. 17, 2026 — Aptitude Medical Systems, Inc. today announced that co-founder JP Wang has been appointed Co-Chief Executive Officer. Wang will lead the company alongside co-founder and Co-CEO Scott Ferguson.

The appointment formalizes Wang and Ferguson’s existing shared leadership of  the company as it expands both the Metrix molecular diagnostic platform and its commercial reach.

Wang co-founded Aptitude with Ferguson and Jackson Gong in 2011. Since then, he has shaped the company’s strategy, vision, and culture while leading much of its work across technology, product development, manufacturing, and operations. He most recently served as President and Chief Technology Officer.

“JP and I have built Aptitude together for more than a decade, and this appointment reflects how we already lead the company,” said Ferguson. “JP has been the driving force behind our product platform, built the capabilities needed to manufacture at scale, and played a central role in shaping the team and culture we have today. We know the business deeply, bring complementary strengths, and share the same vision for its future. Formalizing this structure gives us greater clarity and allows us to move faster as we enter the next stage of growth.”

Aptitude is expanding from a company historically centered on research and product development into a commercial diagnostics company with products in the market and an expanding customer base. Its Metrix platform is designed to bring laboratory-quality molecular testing into homes and point-of-care settings. Aptitude currently offers FDA-authorized molecular tests for COVID-19 and Flu and is expanding both the commercial reach of Metrix and the platform’s test menu.

“We spent many years developing the technology and capabilities required to make high-quality molecular testing broadly accessible,” said Wang. “Our next challenge is to build on that foundation by bringing more tests to the Metrix platform and bringing those products to many more customers. We need to remain as strong at invention and product development as we become at commercial execution. Scott and I have already been leading that work together, and formalizing the Co-CEO structure brings greater clarity both internally and externally.”

The appointment formalizes Aptitude’s existing leadership model and does not change the company’s day-to-day operating structure or its existing relationships with employees, customers, and partners.

About Aptitude Medical Systems
Aptitude Medical Systems is a molecular diagnostics company based in Goleta, California, in the Santa Barbara area. The company develops, manufactures, and commercializes the Metrix platform, which brings laboratory-quality molecular testing to the point of care and the home. Founded in 2011, Aptitude produces FDA-authorized diagnostic products and is expanding the Metrix test menu to address a broader range of diagnostic needs. The company works with commercial and public-sector partners to expand access to molecular testing.

To learn more, visit www.aptitudemedical.com, follow Aptitude on LinkedIn.

SOURCE Aptitude Medical Systems, Inc.